1. Home
  2. NSPR vs IPWR Comparison

NSPR vs IPWR Comparison

Compare NSPR & IPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

SELL

Current Price

$0.60

Market Cap

38.9M

Sector

Health Care

ML Signal

SELL

Logo Ideal Power Inc.

IPWR

Ideal Power Inc.

HOLD

Current Price

$1.93

Market Cap

33.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSPR
IPWR
Founded
2005
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
38.9M
33.9M
IPO Year
2009
2013

Fundamental Metrics

Financial Performance
Metric
NSPR
IPWR
Price
$0.60
$1.93
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $3.33
N/A
AVG Volume (30 Days)
★ 404.0K
124.5K
Earning Date
11-12-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $2,310,000.00
N/A
Revenue This Year
$9.14
$2,550.55
Revenue Next Year
$105.44
$600.00
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.43
$1.90
52 Week High
$2.17
$9.30

Technical Indicators

Market Signals
Indicator
NSPR
IPWR
Relative Strength Index (RSI) 49.18 25.51
Support Level $0.43 $1.90
Resistance Level $0.77 $3.33
Average True Range (ATR) 0.11 0.27
MACD 0.01 -0.01
Stochastic Oscillator 44.74 2.90

Price Performance

Historical Comparison
NSPR
IPWR

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About IPWR Ideal Power Inc.

Ideal Power Inc is engaged in the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.

Share on Social Networks: